Oesophagus Demo 1 Oesophagus Demo Case Study  |  Demo  |  Evidence Screenshot of the Oesophagus TexRAD highlighting the co...
Oesophagus Evidence 1 Oesophagus Early Evidence Clinical Evidence   –  Submitted to ICIS 2010 [1]  Case Study  |  Demo  | ...
Oesophagus Evidence 2 Oesophagus Early Evidence Clinical Evidence  –  Submitted to ICIS 2010 [1] Case Study  |  Demo  |  E...
Contact Dr Balaji Ganeshan TexRAD Principal Developer & Project Manager Clinical Imaging Sciences Centre Brighton & Sussex...
Disclaimer Notice TexRAD is meant to be used as an assistive risk stratification tool in clinical practice and should not ...
Upcoming SlideShare
Loading in …5
×

TexRAD Oesophagus Cancer

593 views
533 views

Published on

TexRAD is a software application that analyses the textures in existing radiological scans to assist the clinician in assessing the prognosis of patients with cancer.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
593
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

TexRAD Oesophagus Cancer

  1. 1. Oesophagus Demo 1 Oesophagus Demo Case Study | Demo | Evidence Screenshot of the Oesophagus TexRAD highlighting the conventional CT image of the oesophagus (top-left), followed by the derived texture maps superimposed on the conventional CT image – fine (red), medium (green) and coarse (blue) texture 5 6 6 7 8 1 2 3 4
  2. 2. Oesophagus Evidence 1 Oesophagus Early Evidence Clinical Evidence – Submitted to ICIS 2010 [1] Case Study | Demo | Evidence Oesophageal tumour with lower uniform coarse texture (or higher metabolic activity - SUV) indicates adverse biology Texture correlates with Tumour Metabolism 5 6 6 7 8 1 2 3 4
  3. 3. Oesophagus Evidence 2 Oesophagus Early Evidence Clinical Evidence – Submitted to ICIS 2010 [1] Case Study | Demo | Evidence Texture identifies patients above stage II 5 6 6 7 8 1 2 3 4
  4. 4. Contact Dr Balaji Ganeshan TexRAD Principal Developer & Project Manager Clinical Imaging Sciences Centre Brighton & Sussex Medical School University of Sussex Brighton BN1 9RR Tel: +44 (0) 7727228107 Email: TexRAD@sussex.ac.uk Contact
  5. 5. Disclaimer Notice TexRAD is meant to be used as an assistive risk stratification tool in clinical practice and should not form the basis for clinical decision making. The results obtained from TexRAD system should only be interpreted by a health care professional. IMPORTANT: TexRAD is being further evaluated and not yet available for routine clinical practice. Disclaimer

×